By Jennifer Popik, J.D.
Late last year, older Americans finished up a period of open
enrollment in which they could choose among competing private health
insurance plans in the “Medicare Advantage” alternative to the
traditional completely government-run Medicare program. While senior
citizens were being asked to choose among plans, the Center for
Medicare and Medicaid Services (CMS) was engaged in a full-out
advertising blitz, attempting to encourage them to base their
decisions on the CMS’s so-called “star ratings” of competing health
insurance plans.
While most older Americans likely assume these accurately reflect
how well the plans deliver lifesaving and health-preserving
treatment, in fact plans with higher survival and recovery rates are
likely to be outranked by those that deliver cheaper care and
emphasize preventive over curative measures, while providing quick
and friendly “customer service.”
The CMS star ratings have been assigned to Medicare Advantage
plans for the last several years. The ratings reflect a “quality
score” that is compiled based on certain performance measures. CMS
rates plans on a scale of 1 to 5 stars, with 5 stars representing
the highest quality in an effort to guide senior consumer choice.
Using this star rating system, CMS has long attempted to steer
seniors into what it calls “high quality” plans.
This year, there are changes to the Medicare program, and they
are among some of the most dramatic changes present in the Obama
Health Care law. Now, the star rating will take on a new and
critical role. Starting in 2012, plans with four or more stars will
receive bonuses along with higher rebates. After next year, there
will be a three-year period of attempting to push plans, using these
bonus payments, into higher star ratings.
These bonus payments will no doubt influence plans to conform
their behavior to that rewarded by the rating system. A professor
who specializes in Medicare economics at George Washington
University, Dr. Brian Biles, estimated that the top-rated plans
would have received $1.3 billion in bonus payments last year if the
bonus plan had been in effect.
There is little doubt that these payments will be important and
can shape the way Medicare Advantage plans are constructed and
administered. So what do the stars really measure? On the surface,
they purport to measure quality. According to the Kaiser Family
Foundation, “The quality scores for Medicare Advantage plans in 2011
are based on 53 performance measures that are derived from plan and
beneficiary information collected in three surveys—HEDIS®, CAHPS®,
and HOS—and administrative data. For example, the performance
measures include whether the plans’ enrollees received the
appropriate screening tests, the number of complaints CMS received
about the plan, and how enrollees rated the communication skills of
the plans’ physicians.”
CMS groups 53 individual quality measures, collected by the four
sources above, into subsets. Thirteen of the 53 measures evaluate
screenings, tests, and vaccines. Seven of the 53 measures evaluate
drug plan customer service. Four measures evaluate prices of drugs.
Three measures evaluate phone service and another three evaluate
plan experience.
Of the 53 measures, each of which is given equal weight, only 10
measures look at a plan’s effectiveness in treating illness and
injury—the outcome in terms of lives saved and health problems
ameliorated. Senior citizens—and all Americans—should be troubled to
learn that it is possible, under this star rating system, to have a
plan that has poor outcomes with cancer treatment outrank another
plan under which a patient is more likely to survive because the
plan under which you are more likely to die is deemed to have better
phone service and lower drug prices.
In fact, there has been much scholarly criticism of the validity
of the rating measures used. To give just one example, high scores
from HEDIS, one of the rating agencies, have been shown not to be
associated with better health outcomes. According to one study, “It
[an asthma control measure] is controversial because compliance with
the HEDIS measure has never been prospectively linked to a better
health outcome for the patients.”
Most patients are well aware that among the different types of
health insurance plans, health maintenance organizations (HMOs) are
those that provide the most tightly managed care. They often limit
treatment and diagnostic options, giving less choice of physicians
(sometimes assigning beneficiaries to specific doctors directly
employed by the HMO), and requiring grudgingly given referrals from
a primary care physician in order to see a specialist. HMOs
frequently put plenty of emphasis on preventive care (free gym
memberships, nutritional and exercise advice) but if you get
seriously (and expensively) sick, you are often less likely to get
the most advanced and effective treatments.
For 2011, just three Medicare Advantage insurance plans (out of a
total of 523 nationwide) received an overall rating of 5 stars—ALL
of them HMOs. Moreover, HMOs have higher average ratings (3.59
stars) than the average overall rating for local Preferred Provider
Organizations or PPOs (3.46 stars), Private Fee-for-Service or PFFS
plans (3.07 stars), and regional PPOs (2.76 stars)—all weighted by
2010 enrollment.
(PPOs and PFFS plans allow patients to go to any doctor they
like, although PPO beneficiaries may pay a higher co-payment for
“out-of-network” health care providers. PFFS plans may allow senior
citizens who choose to do so to add their own money on top of the
government payment in order to get plans less likely to curtail
treatment, although a provision in Obamacare effectively allows CMS
to limit or eliminate this option.)
There is grave reason for concern that treatment that a doctor
and patient deem needed or advisable to save that patient’s life or
preserve or improve the patient’s health may not always translate
into the coveted high star rating. The Medicare Advantage plans will
now be under enormous pressure to get their health providers to stay
within the quality measure not only to get attractive high star
ratings, but also to get greatly desired millions of dollars in
bonus payments. Over time, older Americans may come to find that the
only alternatives available in Medicare are those better at
providing quick, friendly telephone access and cheap drugs than at
saving lives.
There is a broader and related danger. The transition to this
kind of delivery of health care is not going to be limited only to
seniors in the Medicare program; it will extend to all Americans.
The Obama health law also calls for an Independent Payment Advisory
Board (IPAB). The IPAB is charged with making recommendations to
limit growth in private, nongovernmental spending on health to below
the rate of medical inflation. In turn, the Department of Health and
Human Services has the authority to implement those recommendations
by imposing “quality and efficiency” measures on health care
providers.
And these will be standards specifically designed to limit what
ordinary Americans may choose to spend on health care so that it is
BELOW the rate of medical inflation. Treatment that a doctor and
patient deem needed or advisable to save that patient’s life or
preserve or improve the patient’s health but which runs afoul of the
imposed standards will be denied, even if the patient is willing and
able to pay for it.
So for seniors and all Americans alike, there will be—in
effect—one uniform national standard of care, established by
Washington bureaucrats and set with a view to limiting what private
citizens are allowed to spend on saving their own lives. It is more
than likely that the sort of approach reflected in the Medicare
Advantage “star” ratings—subordinating good lifesaving outcomes to
“cost-effectiveness” and good consumer relations—will be
incorporated into the “quality” standards that will be imposed on
all of American medicine.